HSDT logo

HSDT

Profile

Full Name

Helius Medical Technologies, Inc.

Ticker Symbol

HSDT

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

June 27, 2014

Indexes

Not included

Website

http://heliusmedical.com

Employees

21

Key Details

Price

$0.28(-1.79%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$520.00K(-19.25% YoY)

Annual EPS

-$4.33(+70.26% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.28
HSDT price is $0.28

30-Day Relative Volume

0.67
HSDT 30-day relative volume is 0.67

Price Performance

Price Most recent change

-1.79%
HSDT price was down -1.79% on Apr 17, 2025

Price YTD change

-58.96%
HSDT price is down -58.96% since January 1st

Price 1-year change

-94.69%
HSDT price is down -94.69% year-on-year

Price 3-year change

-99.82%
HSDT price is down -99.82% over the past 3 years

Price Range

Price All-time high

$36225.00
HSDT price is currently -100.00% below its historical high of $36225.00

Price 3-year low

$0.27
HSDT price is currently +1.85% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.56M
HSDT market capitalization is $1.56 million

Market cap 3-year change

-86.78%
HSDT market capitalization is down -86.78% over the past 3 years

Market cap All-time high

$383.36M
HSDT market capitalization is currently -99.59% below its historical high of $383.36 million

Market cap sector rank

5.92%
HSDT market capitalization is higher than 5.92% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+539.13%
HSDT shares outstanding is up +539.13% year-on-year

Shares Outstanding 3-Year Change

+7375.89%
HSDT shares outstanding is up +7375.89% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.79
HSDT beta is 0.79

200-day SMA

$0.62
HSDT price is currently -55.46% below its 200-day simple moving average

50-day SMA

$0.44
HSDT price is currently -37.04% below its 50-day simple moving average

RSI

29.21
HSDT 14-day relative strength index is 29.21

Volume

0.67
HSDT 30-day relative volume is 0.67

ATR

$0.04
HSDT average true range is $0.04

10-day Historical Volatility

97.08%
HSDT 10-day historical volatility is 97.08%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$520.00K
HSDT annual revenue is $520.00 thousand

Revenue Analysts estimate

$510.00K
HSDT annual revenue is currently +1.96% higher than the consensus analysts' forecast

Revenue 1-year change

-19.25%
HSDT annual revenue is down -19.25% year-on-year

Revenue Sector rank

9.85%
HSDT annual revenue is higher than 9.85% of companies in Healthcare sector

EPS

EPS

-$4.33
HSDT annual earnings per share is -$4.33

EPS Analysts estimate

-$2.50
HSDT annual earnings per share is currently +73.20% higher than the consensus analysts' forecast

EPS 1-year change

+70.26%
HSDT annual earnings per share is up +70.26% year-on-year

EPS Sector rank

21.74%
HSDT annual earnings per share is higher than 21.74% of companies in Healthcare sector

Profit

Gross profit

-$62.00K
HSDT annual gross profit is -$62.00 thousand

Gross margin

-11.92%
HSDT annual gross profit margin is -11.92%

Operating profit

-$13.86M
HSDT annual operating income is -$13.86 million

Operating margin

-2665.96%
HSDT annual operating profit margin is -2665.96%

Net income

-$11.74M
HSDT annual net profit is -$11.74 million

Net margin

-2258.08%
HSDT annual net profit margin is -2258.08%

Expenses

Total expenses

$14.38M
HSDT annual total expenses is $14.38 million

Operating expenses

$13.80M
HSDT annual total operating expenses is $13.80 million

Cost of goods sold

$582.00K
HSDT annual cost of goods sold is $582.00 thousand

Selling, general & administrative expenses

$10.12M
HSDT annual SGA is $10.12 million

Depreciation and amortization

$60.00K
HSDT annual depreciation & amortization is $60.00 thousand

Interest expense

-
HSDT annual interest expense value is unknown

Income tax

$0.00
HSDT annual income tax is $0.00

EBIT & EBITDA

EBIT

-$13.86M
HSDT annual earnings before interest & taxes is -$13.86 million

EBITDA

-$13.80M
HSDT annual EBITDA is -$13.80 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.54M
HSDT annual total assets is $3.54 million

Non current assets

$118.00K
HSDT annual long term assets is $118.00 thousand

Current assets

$3.42M
HSDT annual total current assets is $3.42 million

Cash and cash equivalents

$1.09M
HSDT annual cash & cash equivalents is $1.09 million

Accounts receivable

$70.00K
HSDT annual accounts receivable is $70.00 thousand

Inventory

$1.09M
HSDT annual inventory is $1.09 million

Liabilities

Total liabilities

$2.48M
HSDT annual total liabilities is $2.48 million

Long term liabilities

$320.00K
HSDT annual total long term liabilities is $320.00 thousand

Current liabilities

$2.16M
HSDT annual total current liabilities is $2.16 million

Accounts payable

$873.00K
HSDT annual accounts payable is $873.00 thousand

Debt

Total debt

$12.00K
HSDT annual total debt is $12.00 thousand

Total debt 1-year change

-78.95%
HSDT annual total debt is down -78.95% year-on-year

Long term debt

$0.00
HSDT annual long term debt is $0.00

Short term debt

$12.00K
HSDT annual short term debt is $12.00 thousand

Equity & Capital

Shareholders equity

$1.06M
HSDT annual stockholders equity is $1.06 million

Book value

$1.06M
HSDT annual book value is $1.06 million

Retained earnings

-$171.70M
HSDT annual retained earnings is -$171.70 million

Working capital

$1.26M
HSDT annual working capital is $1.26 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$11.04M
HSDT annual cash flow from operations is -$11.04 million

Cash from operations 1-year change

-6%
HSDT annual cash flow from operations is down -6% year-on-year

Cash from investing

-$5000.00
HSDT annual cash flow from investing activities is -$5000.00

Cash from investing 1-year change

+82.76%
HSDT annual cash flow from investing activities is up +82.76% year-on-year

Cash from financing

$6.95M
HSDT annual cash flow from financing activities is $6.95 million

Cash from financing 1-year change

+545.68%
HSDT annual cash flow from financing activities is up +545.68% year-on-year

CAPEX

CAPEX

$5000.00
HSDT annual capital expenditures is $5000.00

CAPEX 1-year change

-82.76%
HSDT annual capital expenditures is down -82.76% year-on-year

Free Cash Flow

Free cash flow

-$11.05M
HSDT annual free cash flow is -$11.05 million

Free cash flow 1-year change

-5.75%
HSDT annual free cash flow is down -5.75% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-11.92%
HSDT annual gross profit margin is -11.92%

Operating margin

-2665.96%
HSDT annual operating profit margin is -2665.96%

Net margin

-2258.08%
HSDT annual net profit margin is -2258.08%

ROA & ROE

ROA

-209.04%
HSDT annual return on assets is -209.04%

ROE

-688.88%
HSDT annual return on equity is -688.88%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
HSDT price to earnings ratio value is unknown

PE ratio Sector rank

-
HSDT price to earnings ratio is unknown

PB Ratio

PB ratio

1.47
HSDT price to book ratio is 1.47

PB ratio Sector rank

55.44%
HSDT price to book ratio is higher than 55.44% of companies in Healthcare sector

PS Ratio

PS ratio

3.00
HSDT price to sales ratio is 3.00

PS ratio Sector rank

52.31%
HSDT price to sales ratio is higher than 52.31% of companies in Healthcare sector

Enterprise value

Enterprise value

$484.40K
HSDT enterprise value is $484.40 thousand

Enterprise value Sector rank

12.8%
HSDT enterprise value is higher than 12.8% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.04
HSDT EV/EBITDA is -0.04

EV/EBITDA Sector rank

63.83%
HSDT EV/EBITDA is higher than 63.83% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.58
HSDT annual current ratio is 1.58

Quick ratio

1.08
HSDT annual quick ratio is 1.08

Leverage

Debt to equity

0.00
HSDT annual debt to equity ratio is 0.00

Interest coverage ratio

-
HSDT annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

3
HSDT piotroski f-score is 3

Altman Z-Score

-79.83
HSDT altman z-score is -79.83

Analyst ratings

Recent major analysts updates

Mar 5, 24 Roth MKM
Buy
Mar 24, 21 Noble Capital Markets
Outperform
Apr 16, 19 BTIG Research
Neutral
Apr 11, 19 Oppenheimer
Perform
Mar 6, 19 Oppenheimer
Outperform
Nov 20, 18 BTIG Research
Buy
Jun 20, 18 BTIG Research
Neutral
May 17, 18 BTIG Research
Buy

Institutional Ownership

Similar stocks

ONCT logo
Oncternal Therapeutics (ONCT)
Polyrizon (PLRZ)
AKAN logo
Akanda (AKAN)
AVGR logo
Avinger (AVGR)
FOXO logo
FOXO Technologies (FOXO)
YCBD logo
cbdMD (YCBD)
VINC logo
Vincerx Pharma (VINC)
AWH logo
Aspira Womens Health (AWH)
Scinai Immunotherapeutics (SCNI)
  • What is the ticker symbol for Helius Medical Technologies?
  • Does Helius Medical Technologies pay dividends?
  • What sector is Helius Medical Technologies in?
  • What industry is Helius Medical Technologies in?
  • What country is Helius Medical Technologies based in?
  • When did Helius Medical Technologies go public?
  • Is Helius Medical Technologies in the S&P 500?
  • Is Helius Medical Technologies in the NASDAQ 100?
  • Is Helius Medical Technologies in the Dow Jones?
  • When was Helius Medical Technologies's last earnings report?
  • When does Helius Medical Technologies report earnings?
  • Should I buy Helius Medical Technologies stock now?

What is the ticker symbol for Helius Medical Technologies?

The ticker symbol for Helius Medical Technologies is NASDAQ:HSDT

Does Helius Medical Technologies pay dividends?

No, Helius Medical Technologies does not pay dividends

What sector is Helius Medical Technologies in?

Helius Medical Technologies is in the Healthcare sector

What industry is Helius Medical Technologies in?

Helius Medical Technologies is in the Medical Devices industry

What country is Helius Medical Technologies based in?

Helius Medical Technologies is headquartered in United States

When did Helius Medical Technologies go public?

Helius Medical Technologies's initial public offering (IPO) was on June 27, 2014

Is Helius Medical Technologies in the S&P 500?

No, Helius Medical Technologies is not included in the S&P 500 index

Is Helius Medical Technologies in the NASDAQ 100?

No, Helius Medical Technologies is not included in the NASDAQ 100 index

Is Helius Medical Technologies in the Dow Jones?

No, Helius Medical Technologies is not included in the Dow Jones index

When was Helius Medical Technologies's last earnings report?

Helius Medical Technologies's most recent earnings report was on Nov 12, 2024

When does Helius Medical Technologies report earnings?

The next expected earnings date for Helius Medical Technologies is May 13, 2025

Should I buy Helius Medical Technologies stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page